Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus.
dc.contributor.author | Kumar, A | en_US |
dc.contributor.author | Gupta, R | en_US |
dc.contributor.author | Varghese, T | en_US |
dc.contributor.author | Pande, R M | en_US |
dc.contributor.author | Singal, V K | en_US |
dc.contributor.author | Garg, O P | en_US |
dc.date.accessioned | 1999-12-04 | en_US |
dc.date.accessioned | 2009-05-27T07:05:56Z | |
dc.date.available | 1999-12-04 | en_US |
dc.date.available | 2009-05-27T07:05:56Z | |
dc.date.issued | 1999-12-04 | en_US |
dc.description.abstract | The present study was conducted to examine the usefulness of anti-C1q antibody as a marker of disease activity in Indian patients with systemic lupus erythematosus (SLE). We standardized the assay for detection of IgG anti-C1q antibody using ELISA. The normal cut-off level was determined by testing 57 healthy, age and sex matched controls to be 53 units/m1 (mean +/- 2 SD). Patients with SEL (97 females and 13 males) were studied and the following parameters were obtained on all: SLE disease activity index (SLEDAI), anti-C1q, anti-ds DNA and C3. Correlations were tested between these parameters using Spearman's rank correlation coefficients. Anti-C1q was found positive in 66 (60%) patients while anti-ds DNA was found in 78 (71%). The positive predictive values of anti-C1q and anti-ds DNA for lupus nephritis were 59 and 61 per cent respectively. The titres of anti-C1q correlated positively with SLEDAI (P < 0.01) and anti-ds DNA (P < 0.01) and negatively with C3 levels (P < 0.001). No significant correlation was observed between anti-C1q positivity and any particular organ involvement. Similarly, no correlation was found between anti-C1q and proliferative lupus nephritis. Anti-C1q was found positive in 5 of 9 patients with moderate SLEDAI scores and negative for anti-ds DNA antibody. It is concluded that anti-C1q antibody can serve as a general marker for lupus activity, supplementing the currently used serum markers. | en_US |
dc.description.affiliation | Department of Medicine, All India Institute of Medical Sciences, New Delhi. | en_US |
dc.identifier.citation | Kumar A, Gupta R, Varghese T, Pande RM, Singal VK, Garg OP. Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus. Indian Journal of Medical Research. 1999 Dec; 110(): 190-3 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/19291 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://icmr.nic.in/ijmr/ijmr.htm | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Antibodies --analysis | en_US |
dc.subject.mesh | Antibodies, Antinuclear --analysis | en_US |
dc.subject.mesh | Biological Markers | en_US |
dc.subject.mesh | Complement C1q --immunology | en_US |
dc.subject.mesh | DNA --immunology | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Lupus Erythematosus, Systemic --diagnosis | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.title | Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus. | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |
Files
License bundle
1 - 1 of 1